Viewing Study NCT07071558

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 11:58 PM
Ignite Modification Date: 2026-01-07 @ 7:26 AM
Study NCT ID: NCT07071558
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-09-16
First Post: 2025-07-08
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Study to Evaluate the Safety and Immunogenicity of Investigational Vaccines Using the RSV (Respiratory Syncytial Virus) Monovalent Antigen in Healthy Participants 18 to 49 Years of Age
Sponsor: Sanofi
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Respiratory Syncytial Virus Immunization View
Keywords:

Keywords

Keyword Brief Keyword Text View
None RSV View
None RSV Infection View
None RSV Vaccine View